Acrivon Therapeutics Ownership & Insider Activity

Acrivon Therapeutics (ACRV) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 7.8% of shares outstanding. Institutional investors hold 6.3%. Over the past 90 days, insiders made 8 sales worth $39K.

Shares Outstanding

42.853M

Shares Float

28.711M

Insider Shares Owned

3.335M

Insider % Owned

7.8%

Institutional Shares Held

2.719M

Institutional % Held

6.3%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$39K total

Net Activity

Net Selling

Net Value (90d)

-$39K

Acrivon Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 5, 2026	Mary Miller	CHIEF LEGAL OFFICER	SELL	294.000	$1.99	$585
Aug 25, 2026	Peter BlumeJensen, Kristina Masson	PRESIDENT AND CEO, EVP - BUSINESS OPERATIONS	SELL	14.036K	$2.21	$31K
Aug 18, 2026	Katharine Peterson	CHIEF ACCOUNTING OFFICER	SELL	101.000	$2.01	$203
Aug 18, 2026	Mary Miller	CHIEF LEGAL OFFICER	SELL	185.000	$2.01	$372
Aug 18, 2026	Erick Gamelin	CHIEF DEVELOPMENT OFFICER	SELL	400.000	$2.01	$804
Aug 18, 2026	Eric Devroe	CHIEF OPERATING OFFICER	SELL	604.000	$2.01	$1K
Aug 18, 2026	Peter BlumeJensen, Kristina Masson	PRESIDENT AND CEO, EVP - BUSINESS OPERATIONS	SELL	1.713K	$2.01	$3K
Aug 4, 2026	Adam D Levy	CHIEF FINANCIAL OFFICER	SELL	1.142K	$1.57	$2K
Jul 21, 2026	Mary Miller	CHIEF LEGAL OFFICER	SELL	573.000	$1.76	$1K